![](/img/cover-not-exists.png)
851 Cost-effectiveness of treatment with zoledronic acid (Zometa®) in prostate cancer patients
K. El ouagari, J.F. BaladiVolume:
1
Year:
2003
Language:
english
DOI:
10.1016/s1359-6349(03)90877-9
File:
PDF, 172 KB
english, 2003